hyster-yale - HY

HY

Close Chg Chg %
34.87 1.70 4.86%

Closed Market

36.56

+1.70 (4.86%)

Volume: 112.87K

Last Updated:

Feb 6, 2026, 3:59 PM EDT

Company Overview: hyster-yale - HY

HY Key Data

Open

$35.33

Day Range

35.33 - 36.69

52 Week Range

26.41 - 57.89

Market Cap

$630.09M

Shares Outstanding

17.73M

Public Float

9.49M

Beta

1.55

Rev. Per Employee

N/A

P/E Ratio

236.32

EPS

$0.16

Yield

410.80%

Dividend

$0.36

EX-DIVIDEND DATE

Dec 1, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

95.21K

 

HY Performance

1 Week
 
9.06%
 
1 Month
 
11.29%
 
3 Months
 
7.07%
 
1 Year
 
-30.02%
 
5 Years
 
-62.10%
 

HY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About hyster-yale - HY

Hyster-Yale, Inc. engages in the manufacture of lift trucks. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), and Japan and Asia Pasific (JAPIC), Bolzoni, and Nuvera. The Americas include the United States, Canada, Mexico, Brazil, Latin America, and the corporate headquarters. The JAPIC segment involves the operations in the Asia and Pacific regions, China, and the equity earnings. The Bolzoni segment focuses on the distribution and production of attachments, forks, and lift tables marketed under the Bolzoni, Auramo, and Meyer brand names. The Nuvera segment consists of design, manufacture, and sale of hydrogen fuel cell stacks and engines. The company was founded in 1999 and is headquartered in Cleveland, OH.

HY At a Glance

Hyster-Yale, Inc.
5875 Landerbrook Drive
Cleveland, Ohio 44124-4069
Phone 1-440-449-9600 Revenue 4.31B
Industry Industrial Machinery Net Income 142.30M
Sector Producer Manufacturing 2024 Sales Growth 4.611%
Fiscal Year-end 12 / 2025 Employees 8,500
View SEC Filings

HY Valuation

P/E Current 236.32
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 6.339
Price to Sales Ratio 0.209
Price to Book Ratio 1.867
Price to Cash Flow Ratio 5.28
Enterprise Value to EBITDA 3.811
Enterprise Value to Sales 0.317
Total Debt to Enterprise Value 0.397

HY Efficiency

Revenue/Employee 506,847.059
Income Per Employee 16,741.176
Receivables Turnover 8.821
Total Asset Turnover 2.097

HY Liquidity

Current Ratio 1.355
Quick Ratio 0.642
Cash Ratio 0.091

HY Profitability

Gross Margin 21.779
Operating Margin 7.216
Pretax Margin 5.083
Net Margin 3.303
Return on Assets 6.927
Return on Equity 32.902
Return on Total Capital 13.994
Return on Invested Capital 19.032

HY Capital Structure

Total Debt to Total Equity 114.039
Total Debt to Total Capital 53.28
Total Debt to Total Assets 26.70
Long-Term Debt to Equity 68.849
Long-Term Debt to Total Capital 32.166
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Hyster-yale - HY

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
3.08B 3.55B 4.12B 4.31B
Sales Growth
+9.37% +15.37% +16.06% +4.61%
Cost of Goods Sold (COGS) incl D&A
2.71B 3.05B 3.29B 3.37B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
46.20M 43.40M 45.10M 47.60M
Depreciation
40.80M 38.90M 40.80M 43.30M
Amortization of Intangibles
5.40M 4.50M 4.30M 4.30M
COGS Growth
+16.04% +12.53% +8.00% +2.39%
Gross Income
367.70M 501.10M 827.20M 938.30M
Gross Income Growth
-23.14% +36.28% +65.08% +13.43%
Gross Profit Margin
+11.96% +14.12% +20.09% +21.78%
2021 2022 2023 2024 5-year trend
SG&A Expense
445.80M 469.90M 575.00M 627.40M
Research & Development
108.30M 100.70M 119.70M 135.90M
Other SG&A
337.50M 369.20M 455.30M 491.50M
SGA Growth
+8.44% +5.41% +22.37% +9.11%
Other Operating Expense
- - - -
-
Unusual Expense
76.80M 35.60M 6.20M 31.60M
EBIT after Unusual Expense
(154.90M) (4.40M) 246.00M 279.30M
Non Operating Income/Expense
18.70M (28.40M) (21.40M) (54.00M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
11.70M 11.00M 9.80M 5.50M
Interest Expense
18.70M 29.60M 43.60M 6.30M
Interest Expense Growth
+19.87% +58.29% +47.30% -85.55%
Gross Interest Expense
18.70M 29.60M 43.60M 6.30M
Interest Capitalized
- - - -
-
Pretax Income
(154.90M) (62.40M) 181.00M 219.00M
Pretax Income Growth
-467.06% +59.72% +390.06% +20.99%
Pretax Margin
-5.04% -1.76% +4.40% +5.08%
Income Tax
28.30M 9.20M 52.90M 74.80M
Income Tax - Current - Domestic
(100.00K) 1.10M 40.00M 65.80M
Income Tax - Current - Foreign
8.60M 8.20M 14.00M 17.20M
Income Tax - Deferred - Domestic
17.90M 2.20M 600.00K 200.00K
Income Tax - Deferred - Foreign
1.90M (2.30M) (1.70M) (8.40M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
11.70M 11.00M 9.80M 5.50M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(183.20M) (71.60M) 128.10M 144.20M
Minority Interest Expense
(10.20M) 2.50M 2.20M 1.90M
Net Income
(173.00M) (74.10M) 125.90M 142.30M
Net Income Growth
-566.31% +57.17% +269.91% +13.03%
Net Margin Growth
-5.62% -2.09% +3.06% +3.30%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(173.00M) (74.10M) 125.90M 142.30M
Preferred Dividends
- - - -
-
Net Income Available to Common
(173.00M) (74.10M) 125.90M 142.30M
EPS (Basic)
-10.2866 -4.3844 7.3467 8.1585
EPS (Basic) Growth
-565.12% +57.38% +267.56% +11.05%
Basic Shares Outstanding
16.82M 16.90M 17.14M 17.44M
EPS (Diluted)
-10.2866 -4.3844 7.2419 8.035
EPS (Diluted) Growth
-565.77% +57.38% +265.17% +10.95%
Diluted Shares Outstanding
16.82M 16.90M 17.39M 17.71M
EBITDA
(31.90M) 74.60M 297.30M 358.50M
EBITDA Growth
-128.95% +333.86% +298.53% +20.59%
EBITDA Margin
-1.04% +2.10% +7.22% +8.32%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 36.50
Number of Ratings 2 Current Quarters Estimate -1.33
FY Report Date 03 / 2026 Current Year's Estimate -1.445
Last Quarter’s Earnings -2.005 Median PE on CY Estimate N/A
Year Ago Earnings -2.44 Next Fiscal Year Estimate 1.79
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 2 1
Mean Estimate -1.33 -0.76 -1.45 1.79
High Estimates -1.33 -0.76 -1.40 1.79
Low Estimate -1.33 -0.76 -1.49 1.79
Coefficient of Variance N/A N/A -4.40 N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Hyster-yale - HY

Date Name Shares Transaction Value
Sep 12, 2025 John P. Jumper Director 25,874 Other acquisition or disposition 0.00
Apr 3, 2025 Gary L. Collar Director 3,532 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 3, 2025 Edward T. Eliopoulos Director 12,536 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 3, 2025 Hara Ann O Director 1,085 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 3, 2025 Carolyn Corvi Director 24,274 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 3, 2025 Harold Vincent Poor Director 18,540 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 3, 2025 Britton T. Taplin Director 385,206 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 3, 2025 Dennis W. LaBarre Director 33,698 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 3, 2025 Gary L. Collar Director 3,024 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2025 John C. Butler Director 55,074 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2025 Colleen R. Batcheler Director 4,905 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2025 James B. Bemowski Director 16,772 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 17, 2025 Margo J V Williams Director 983 Other acquisition or disposition 0.00
Mar 17, 2025 Helen Charles Williams Director 983 Other acquisition or disposition 0.00
Mar 17, 2025 Griffin B Butler Director 983 Other acquisition or disposition 0.00
Mar 17, 2025 Clara R Butler Director 983 Other acquisition or disposition 0.00
Mar 17, 2025 Amr Associates LP Chairman; Director 19,118 Other acquisition or disposition 0.00
Mar 17, 2025 Amr Associates LP 1,967 Other acquisition or disposition 0.00
Mar 17, 2025 Amr Associates LP 1,967 Other acquisition or disposition 0.00
Mar 17, 2025 Amr Associates LP Director 1,967 Other acquisition or disposition 0.00

Hyster-Yale in the News